期刊文献+

病灶刮除骨水泥充填术治疗骨盆四肢转移性骨肿瘤 被引量:1

Curettage plus cement reconstruction in the treatment of metastatic tumors of pelvis or limbs
暂未订购
导出
摘要 目的评价骨水泥病灶充填术治疗骨盆四肢转移性骨肿瘤的疗效和适应证.方法52例骨盆四肢转移性肿瘤患者,34例采用肿瘤刮除加骨水泥病灶充填或加内固定治疗,18例采用植骨或截肢治疗.术后随访生存时间、疼痛改善程度和生存质量.结果随访5~62个月,术后1、2、3年生存率骨水泥组分别为91.2%、82.4%、52.9%,非骨水泥组分别为44.4%、22.2%、11.1%.术后1个月疼痛改善有效率骨水泥组为88.2%,非骨水泥组为33.3%.术后生存质量提高和稳定率骨水泥组为76.5%,非骨水泥组为33.3%.经χ2检验两组差异有显著性(P<0.05).结论骨水泥病灶充填治疗骨盆四肢转移性骨肿瘤能提高生存时间,改善生活质量. Objective To evaluate the effects and indications of curettage plus cement reconstruction in the treatment of metastatic tumors of pelvis or limbs. Methods 52 patients with metastatic tumors of pelvis or limbs were divided into 2 groups. The bone cement group(34 cases) were treated with curettage plus cement reconstruction, and some of which accepted internal fixation. The control group( 18 cases) were treated with amputation or curettage plus bone graft. The survival duration, pain improvement and life quality were followed up,postoperatively. Results The postoperative follow-up ranged from 5 to 62 months. The postoperative survival rates at one year, two years, and three years of bone cement group were 91.2% ,82. 4% and 52. 9% , those of the control group were 44. 4% , 22.2% and 11.1% , respectively. In 1 month after operation, the pain was relieved in 30 cases (88.2%) in bone cement group and 18 cases (33.3%) in control group. The life quality improvement and stability rate was 76.5% in bone cement group, and 33.3% in control group. X^2 test showed significant difference between the two groups(P 〈 0. 05). Conchlsions Curettage plus cement reconstruction is effective in treating metastatic tumors of pelvis or limbs. It can prolong the life expectancy and improve the life qualities.
出处 《临床骨科杂志》 2005年第4期331-333,共3页 Journal of Clinical Orthopaedics
关键词 骨肿瘤/外科学 肿瘤转移 bone neoplasm/surgery neoplasm metastasis
  • 相关文献

参考文献7

二级参考文献17

  • 1Pavlidis N, Kalef EJ, Briassoulis E et al. Evaluation of six tumors in patients with carcinoma of unknown primary[J]. Med Pediatr Oncol, 1994;22(3):162~167
  • 2Wedin R, Bauer HC, Skoog L et al. Cytological diagnosis of skeletal lesions. Fine-veedle aspiration biopsy in 110 tumours[J]. J Bone Joint Surg Br, 2000;82(5):673~678
  • 3Bortolus R, Roncadin M, Arcicasa M. Unknown primary bone metastasis: therapeutic and diagnostic strategies[J]. Radiol Med (Torino), 1993;85(4):406~410
  • 4Jacobsen S, Stephensen SL, Paaske BP et al. Skeletal metastases of unknown origin: a retrospective analysis of 29 cases[J]. Acta Orthop Belg, 1997; 63(1):15~22
  • 5Katagiri H, Takahashi M, Inagaki J. Determining the site of the primary cancer in patients with skeletal metastasis of unknown origin: a retrospective study[J]. Cancer, 1999;86(3):533~537
  • 6杨克勤.脊柱疾病[M].北京:北京出版社,1993.493-498.
  • 7Sim F H,Clin Orthop,1995年,312卷,160页
  • 8Murphy KJ,Deramond H. Percutaneous vertebroplasty in benign and malignant disease [J].Neruroimaging Clin N Am,2000,10 (3):535-545.
  • 9Cotten A,Dewatre F,Cortet B,et al. Percutaneous vertebroplasty for osteolytic metastases and myeloma: effects of the percent age of lesion filling and the leakage of methylmethacrylate at clinical follow-up[J].Radiology, 1996,200 (2) :525-530.
  • 10Mathis JM,Barr JD,Belkoff SM,et al.Percutaneous vertebroplas ty:a developing standard of care for vertebral compression fractures[J]. AJNR Am J Neuroradiol,2001,22(2):373-381.

共引文献35

同被引文献15

  • 1[2]Bozic KJ,Jocobs JJ.Why the bearing surface matters:the problems caused by bearing surface wear.Seminars in Arthroplasty,2003,14:578.
  • 2[3]Harris WH,Muratoglu OK,A review of current cross-linked polyethylene used in total joint arthroplasty.Clin Orthop,2005,430:462.
  • 3[4]Bradgon CR,Jasty M,Muratoglu OK,et al.Third-body wear testing of a highly cross-linked acetabular liner.J Arthroplasty,2005,20:37985.
  • 4[6]Bourne RB.Prophylactic use of antibiotic bone cement.J Arthroplasty,2004,19(Suppl 1):69-72.
  • 5[7]Kuehn KD,Ege W,Copp U.Acrylic bone cements:mechanical and physical priperties.Orthop Clin North Am,2005,36:29-39.
  • 6[8]Garvin K,Feschuk C.Polylactide-polyglycolide antibiotic implants.Clin Orthop,2005,437:105-110.
  • 7[9]Rose FR,Oxeffo RO.Bone tissue engineering:hope VS hype.Biochem Biophys Res Common,2002,292:1.
  • 8[10]Berkland C,Pollauf E,Pack DW,et al.Uniform double-walled polymer microspheres of controllable shell thichness.J Controlled Release,2004,96:101-111.
  • 9[12]Martini D,Fini M,Franchi M,et al.Detachment of titanium and fluorohydroxyapatite particles in unloaded endosseous in plants.Biomaterials,2003,1309-1316.
  • 10[13]Tsao AK,Roberson JR,Christie MJ,et al.Biomechanical and clinical evaluations of a porous tantalum implant for the treatment of earlystage osteonecrosis.J Bone Joint Surg Am,2005,87(Suppl 2):22-27.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部